vs
Side-by-side financial comparison of DYNAVAX TECHNOLOGIES CORP (DVAX) and Repay Holdings Corp (RPAY). Click either name above to swap in a different company.
DYNAVAX TECHNOLOGIES CORP is the larger business by last-quarter revenue ($94.9M vs $78.6M, roughly 1.2× Repay Holdings Corp). DYNAVAX TECHNOLOGIES CORP runs the higher net margin — 28.4% vs -178.3%, a 206.7% gap on every dollar of revenue. On growth, DYNAVAX TECHNOLOGIES CORP posted the faster year-over-year revenue change (17.7% vs 0.4%). DYNAVAX TECHNOLOGIES CORP produced more free cash flow last quarter ($32.6M vs $23.2M). Over the past eight quarters, DYNAVAX TECHNOLOGIES CORP's revenue compounded faster (30.6% CAGR vs -1.3%).
Dynavax Technologies Corp is a commercial-stage biopharmaceutical company specializing in the research, development, and production of innovative vaccines and immunotherapies for infectious diseases. Its lead approved product is Heplisav-B, an adult hepatitis B vaccine, with core markets in North America and Europe, alongside a pipeline of candidates addressing unmet public health needs.
Repay Holdings Corp is a leading payment technology provider delivering integrated end-to-end payment processing solutions for businesses across North America. Its offerings include credit/debit card processing, ACH transfer services, POS system integrations and digital payment tools, serving retail, healthcare, automotive and e-commerce segments to help clients streamline transaction workflows and boost operational efficiency.
DVAX vs RPAY — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $94.9M | $78.6M |
| Net Profit | $26.9M | $-140.1M |
| Gross Margin | — | 74.2% |
| Operating Margin | 22.4% | -182.2% |
| Net Margin | 28.4% | -178.3% |
| Revenue YoY | 17.7% | 0.4% |
| Net Profit YoY | 53.0% | -3304.1% |
| EPS (diluted) | $0.21 | $-1.68 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $78.6M | ||
| Q3 25 | $94.9M | $77.7M | ||
| Q2 25 | $95.4M | $75.6M | ||
| Q1 25 | $68.2M | $77.3M | ||
| Q4 24 | $72.0M | $78.3M | ||
| Q3 24 | $80.6M | $79.1M | ||
| Q2 24 | $73.8M | $74.9M | ||
| Q1 24 | $50.8M | $80.7M |
| Q4 25 | — | $-140.1M | ||
| Q3 25 | $26.9M | $-6.4M | ||
| Q2 25 | $18.7M | $-102.3M | ||
| Q1 25 | $-96.1M | $-7.9M | ||
| Q4 24 | $7.0M | $-4.1M | ||
| Q3 24 | $17.6M | $3.2M | ||
| Q2 24 | $11.4M | $-4.1M | ||
| Q1 24 | $-8.7M | $-5.2M |
| Q4 25 | — | 74.2% | ||
| Q3 25 | — | 74.4% | ||
| Q2 25 | — | 75.7% | ||
| Q1 25 | — | 75.9% | ||
| Q4 24 | — | 76.3% | ||
| Q3 24 | — | 77.8% | ||
| Q2 24 | — | 78.2% | ||
| Q1 24 | — | 76.2% |
| Q4 25 | — | -182.2% | ||
| Q3 25 | 22.4% | -3.9% | ||
| Q2 25 | 15.1% | -138.7% | ||
| Q1 25 | -34.7% | -4.7% | ||
| Q4 24 | -2.3% | -1.5% | ||
| Q3 24 | 12.5% | -0.9% | ||
| Q2 24 | 7.0% | -4.6% | ||
| Q1 24 | -35.0% | -3.1% |
| Q4 25 | — | -178.3% | ||
| Q3 25 | 28.4% | -8.3% | ||
| Q2 25 | 19.6% | -135.2% | ||
| Q1 25 | -141.0% | -10.3% | ||
| Q4 24 | 9.8% | -5.3% | ||
| Q3 24 | 21.8% | 4.1% | ||
| Q2 24 | 15.4% | -5.4% | ||
| Q1 24 | -17.2% | -6.5% |
| Q4 25 | — | $-1.68 | ||
| Q3 25 | $0.21 | $-0.08 | ||
| Q2 25 | $0.14 | $-1.15 | ||
| Q1 25 | $-0.77 | $-0.09 | ||
| Q4 24 | $0.07 | $-0.04 | ||
| Q3 24 | $0.12 | $0.03 | ||
| Q2 24 | $0.08 | $-0.04 | ||
| Q1 24 | $-0.07 | $-0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $160.2M | $115.7M |
| Total DebtLower is stronger | — | $280.1M |
| Stockholders' EquityBook value | $534.1M | $484.4M |
| Total Assets | $946.5M | $1.2B |
| Debt / EquityLower = less leverage | — | 0.58× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $115.7M | ||
| Q3 25 | $160.2M | $95.7M | ||
| Q2 25 | $99.1M | $162.6M | ||
| Q1 25 | $51.7M | $165.5M | ||
| Q4 24 | $95.9M | $189.5M | ||
| Q3 24 | $119.3M | $168.7M | ||
| Q2 24 | $112.5M | $147.1M | ||
| Q1 24 | $132.0M | $128.3M |
| Q4 25 | — | $280.1M | ||
| Q3 25 | — | $279.5M | ||
| Q2 25 | — | $279.0M | ||
| Q1 25 | — | $497.6M | ||
| Q4 24 | — | $496.8M | ||
| Q3 24 | — | $496.2M | ||
| Q2 24 | — | $435.6M | ||
| Q1 24 | — | $434.9M |
| Q4 25 | — | $484.4M | ||
| Q3 25 | $534.1M | $616.9M | ||
| Q2 25 | $494.2M | $633.7M | ||
| Q1 25 | $530.9M | $755.7M | ||
| Q4 24 | $596.8M | $761.3M | ||
| Q3 24 | $681.4M | $754.7M | ||
| Q2 24 | $642.8M | $815.4M | ||
| Q1 24 | $618.5M | $813.8M |
| Q4 25 | — | $1.2B | ||
| Q3 25 | $946.5M | $1.3B | ||
| Q2 25 | $918.4M | $1.4B | ||
| Q1 25 | $945.9M | $1.5B | ||
| Q4 24 | $986.3M | $1.6B | ||
| Q3 24 | $1.1B | $1.6B | ||
| Q2 24 | $1.0B | $1.5B | ||
| Q1 24 | $986.6M | $1.5B |
| Q4 25 | — | 0.58× | ||
| Q3 25 | — | 0.45× | ||
| Q2 25 | — | 0.44× | ||
| Q1 25 | — | 0.66× | ||
| Q4 24 | — | 0.65× | ||
| Q3 24 | — | 0.66× | ||
| Q2 24 | — | 0.53× | ||
| Q1 24 | — | 0.53× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $33.8M | $23.3M |
| Free Cash FlowOCF − Capex | $32.6M | $23.2M |
| FCF MarginFCF / Revenue | 34.4% | 29.6% |
| Capex IntensityCapex / Revenue | 1.3% | 0.1% |
| Cash ConversionOCF / Net Profit | 1.26× | — |
| TTM Free Cash FlowTrailing 4 quarters | $80.5M | $90.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $23.3M | ||
| Q3 25 | $33.8M | $32.2M | ||
| Q2 25 | $23.4M | $33.1M | ||
| Q1 25 | $-19.6M | $2.5M | ||
| Q4 24 | $53.0M | $34.3M | ||
| Q3 24 | $19.5M | $60.1M | ||
| Q2 24 | $10.7M | $31.0M | ||
| Q1 24 | $-16.7M | $24.8M |
| Q4 25 | — | $23.2M | ||
| Q3 25 | $32.6M | $32.1M | ||
| Q2 25 | $22.0M | $33.0M | ||
| Q1 25 | $-23.6M | $2.4M | ||
| Q4 24 | $49.5M | $34.0M | ||
| Q3 24 | $18.1M | $59.8M | ||
| Q2 24 | $9.9M | $30.5M | ||
| Q1 24 | $-17.4M | $24.7M |
| Q4 25 | — | 29.6% | ||
| Q3 25 | 34.4% | 41.3% | ||
| Q2 25 | 23.0% | 43.6% | ||
| Q1 25 | -34.6% | 3.0% | ||
| Q4 24 | 68.8% | 43.5% | ||
| Q3 24 | 22.5% | 75.6% | ||
| Q2 24 | 13.5% | 40.7% | ||
| Q1 24 | -34.3% | 30.6% |
| Q4 25 | — | 0.1% | ||
| Q3 25 | 1.3% | 0.2% | ||
| Q2 25 | 1.5% | 0.1% | ||
| Q1 25 | 5.8% | 0.2% | ||
| Q4 24 | 4.8% | 0.3% | ||
| Q3 24 | 1.7% | 0.3% | ||
| Q2 24 | 1.1% | 0.6% | ||
| Q1 24 | 1.5% | 0.1% |
| Q4 25 | — | — | ||
| Q3 25 | 1.26× | — | ||
| Q2 25 | 1.25× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 7.52× | — | ||
| Q3 24 | 1.11× | 18.52× | ||
| Q2 24 | 0.94× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DVAX
| HEPLISAVB | $90.0M | 95% |
| US Department Of Defense | $4.7M | 5% |
RPAY
| Sales Channel Directly To Consumer | $69.4M | 88% |
| Other | $6.8M | 9% |
| Sales Channel Through Intermediary | $2.3M | 3% |
